A detailed history of Concurrent Investment Advisors, LLC transactions in Haleon PLC stock. As of the latest transaction made, Concurrent Investment Advisors, LLC holds 15,271 shares of HLN stock, worth $131,483. This represents 0.01% of its overall portfolio holdings.

Number of Shares
15,271
Previous 14,869 2.7%
Holding current value
$131,483
Previous $122 Million 5.95%
% of portfolio
0.01%
Previous 0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 07, 2024

BUY
$8.02 - $8.67 $3,224 - $3,485
402 Added 2.7%
15,271 $130 Million
Q4 2023

Apr 15, 2024

BUY
$7.78 - $8.62 $115,680 - $128,170
14,869 New
14,869 $122 Million

Others Institutions Holding HLN

About Haleon plc


  • Ticker HLN
  • Exchange
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 4,617,290,240
  • Market Cap $39.8B
  • Description
  • Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, mineral...
More about HLN
Track This Portfolio

Track Concurrent Investment Advisors, LLC Portfolio

Follow Concurrent Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Concurrent Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Concurrent Investment Advisors, LLC with notifications on news.